Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin and Subcutaneous Tissue Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06641076
What this trial is testing

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug

Who this might be right for
Arthritis, Psoriatic
MoonLake Immunotherapeutics AG 960
Early research (Phase 1)Study completedNCT02173392
What this trial is testing

A Bioequivalence Study Comparing a Single 1.5mL Dose of Brodalumab vs. Two Doses (1.0mL + 0.5mL) of Brodalumab

Who this might be right for
Psoriasis
Bausch Health Americas, Inc. 145
Large-scale testing (Phase 3)Looking for participantsNCT07430306
What this trial is testing

Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
AstraZeneca 245
Testing effectiveness (Phase 2)Study completedNCT02076633
What this trial is testing

Intratumoral Administration of L19IL2/L19TNF

Who this might be right for
Malignant Melanoma, Skin
Philogen S.p.A. 21
Not applicableNo Longer AvailableNCT03554434
What this trial is testing

An Expanded Access Program for AM0010 (Pegilodecakin)

Who this might be right for
MelanomaProstate CancerOvarian Cancer+6 more
Eli Lilly and Company
Testing effectiveness (Phase 2)Study completedNCT02962960
What this trial is testing

Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult Type I Interferon Test High Systemic Lupus Erythematosus Subject With Active Skin Manifestations

Who this might be right for
Systemic Lupus Erythematosus
AstraZeneca 36
Not applicableStudy completedNCT04063722
What this trial is testing

Modified Benelli Procedure For Subcutaneous Mastectomy

Who this might be right for
GynecomastiaSurgical Incision
Al-Kindy College of Medicine 150
Early research (Phase 1)Study completedNCT04885829
What this trial is testing

Comparative Study of 3 Tocilizumab Products in Normal Healthy Volunteeers

Who this might be right for
Rheumatoid ArthritisGiant Cell Arteritis
Syneos Health 300
Post-approval studies (Phase 4)Ended earlyNCT02659150
What this trial is testing

Effect of Subcutaneous ACTEMRA on Inflamed Atherosclerotic Plaques in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Massachusetts General Hospital 16
Not applicableUnknownNCT03880188
What this trial is testing

Long Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds

Who this might be right for
Wounds and InjuriesWound InfectionFacial Bones Fracture+16 more
Dufresne, Craig, MD, PC 20
Testing effectiveness (Phase 2)Study completedNCT02196558
What this trial is testing

E6011 in Japanese Subjects With Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Eisai Co., Ltd. 53
Large-scale testing (Phase 3)WithdrawnNCT02074020
What this trial is testing

CHABLIS-SC2: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis

Who this might be right for
Systemic Lupus Erythematosus
Anthera Pharmaceuticals
Early research (Phase 1)Study completedNCT04601389
What this trial is testing

Study of Pharmacokinetics, Pharmacodynamics and Safety Assessment of GNR-044 (JSC GENERIUM, Russia) and Xolair®

Who this might be right for
Healthy Volunteers
AO GENERIUM 84
Testing effectiveness (Phase 2)Study completedNCT01756157
What this trial is testing

Subcutaneous CINRYZE With Recombinant Human Hyaluronidase for Prevention of Angioedema Attacks

Who this might be right for
Hereditary Angioedema (HAE)
Shire 47
Large-scale testing (Phase 3)Study completedNCT03713632
What this trial is testing

Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS)

Who this might be right for
Hidradenitis Suppurativa
Novartis Pharmaceuticals 545
Early research (Phase 1)Study completedNCT00091338
What this trial is testing

Interleukin-7 and Vaccine Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT05960708
What this trial is testing

A Single Dose, Phase 1 Study of YH35324 in Patients with Various Allergic Diseases

Who this might be right for
Allergic DiseaseChronic Spontaneous UrticariaChronic Inducible Urticaria+1 more
Yuhan Corporation 30
Testing effectiveness (Phase 2)Ended earlyNCT01059448
What this trial is testing

Safety and Efficacy of AMG 827 in Subjects With RA

Who this might be right for
Rheumatoid Arthritis
Amgen 211
Early research (Phase 1)Ended earlyNCT00005993
What this trial is testing

Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer

Who this might be right for
Breast CancerLymphoma
Masonic Cancer Center, University of Minnesota
Large-scale testing (Phase 3)Study completedNCT01555125
What this trial is testing

First Study of Secukinumab in Pre-filled Syringes in Subjects With Chronic Plaque-type Psoriasis: Response at 12 Weeks

Who this might be right for
Moderate to Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 177
Next Page